Loading insider details...
Beta
Latest Form 4 (Aug 14, 2026): Exercise/Conversion of 29,849 SUPN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 14, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Exercise/Conversion | 29,849 | n/a |
| Jul 31, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 29,849 | n/a |
| Jun 22, 2026 | COGNITION THERAPEUTICS INC (CGTX) | Grant/Award | 25,000 | n/a |
| Mar 16, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Other (see footnotes) | 12,500 | n/a |
| Mar 10, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Exercise/Conversion | 38,640 | n/a |
| Mar 3, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 38,640 | n/a |
| Feb 20, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 341,610 | n/a |
| Oct 10, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Exercise/Conversion | 81,250 | $2.06M |
| Oct 7, 2025 | scPharmaceuticals Inc. (SCPH) | Tender of Shares | 5,000 | n/a |
| Oct 3, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Exercise/Conversion | 20,000 | n/a |